MarketPulse | Jan 10, 2021 12:39AM ET
What an extraordinary start to the year. US politics is unlikely to go quiet with talk continuing of possible impeachment proceedings against President Trump, COVID is wreaking havoc once again and earnings season gets underway on Friday.
h2 US/h2The US is supposed to be entering the peak of the holiday COVID surge, but it could get much worse now that more states have found the highly contagious UK virus variant. ICU space is tightening across many states and it seems only a matter of time before lockdown efforts are implemented.
For many traders, this week is all about Fed Speak as policymakers will have 11 different events to voice any changes to their outlook now that it seems the economy will finally get more fiscal support. The Fed will also release their Beige Book on Wednesday.
The main economic data event of the week will be if the December retail sales report showed a third consecutive month of declines. Many investors will also pay attention to Friday’s bank earnings to get the latest assessment on strength of the US consumer.
h2 US Politics/h2After the Capitol riot and Trump’s concession that a new administration will be inaugurated on Jan. 20, Wall Street will keep the focus on President-elect Biden’s appointments and clarity on his 100-day agenda. Impeachment proceedings may dominate the headlines, but will have little impact on financial markets.
h2 EU/h2ECB minutes the only notable release next week. The vaccine rollout is continuing after eventually receiving approval, while restrictions continue to be severe during a brutal winter wave.
h2 Brexit/h2The UK and EU agreed a Brexit deal late in December but coming so late in the day means it’s only gone into force on a provisional basis. The European Parliament will scrutinize the deal, but ratification is expected to be a formality, given MEP’s have been kept in the loop on the progress of negotiations throughout.
Talks aren’t over yet, with negotiations now starting on the UK’s access to the EU on financial services, which the former is hoping will be wrapped up by March. This was not included in the initial agreement which focused primarily on goods. The UK is hoping to be granted equivalence but this is far from guaranteed, with the EU reportedly concerned about the countries desire to diverge away from its rules.
h2 UK/h2It’s looking a little bleak for the UK at the moment, with the country back in lockdown until at least the middle of February and London Mayor Sadiq Khan claiming the city is at crisis point due to pressure on the hospitals, with the number already 35% above April’s peak. On the upside, the UK this week approved its third COVID-19 vaccine, with Moderna (NASDAQ:MRNA) following Pfizer (NYSE:PFE) and AstraZeneca (NASDAQ:AZN) in gaining authorization.
While this won’t address any immediate problems in the country, it will contribute to the optimism from the second quarter, although its approval was already built into expectations.
The country may have averted one crisis in agreeing a Brexit deal late in December but it’s very much in the middle of another and there will once again be significant economic consequences of the latest measures, which were arguably inevitable regardless of the new strains.
Turkish markets and the currency are back in favour over the last couple of months, following the personnel changes and rate hikes that went a long way to restoring confidence. In recent years, the country has never been too far away from a crisis but those risks have seemingly subsided in the near-term.
h2 China/h2China inflation expected to move back above 0.0%, mostly due to increasing commodity prices. Thursday Balance of Trade. A fall below $70 billion could trigger fears that international demand is falling and be negative for China equities.
Equity markets are struggling to digest the US delisting of China telcos and their removal from important tracking indices from MSCI/S&P, while a number of payment apps were also banned in the US.
More importantly, antitrust investigations on Alibaba (NYSE:BABA)/Ant Financial are weighing on tech sector giants such as Tencent (NYSE:TME). The Chinese government has ordered the censoring of news around its antitrust investigations. China equities to underperform until more clarity is gained.
The PBOC is showing signs that it is becoming less tolerant of Yuan appreciation, based on this week’s CNY fixes. A US dollar rally due to higher US yields could see a major squeeze of long CNY, long Asian currency positions next week.
h2 India/h2A continued rise in US yields may offset recent INR strength. The currency has shown signs of waning upside momentum this week, and could face further depreciation next week.
India releases Industrial Production on Monday which is expected to recover modestly. WPI on Wednesday will show that India continues to struggle with stagflation, notably because of food price increases. The recent oil rally will add to those woes.
Overall India continues to grapple with a stagflationary environment complicated by a COVID-19 fall in domestic consumption and a weak financial sector.
h2 New Zealand /h2No significant data, Currency may correct lower if US yields continue rising next week.
h2 Australia /h2COVID-19 fears are rising as a community case of the UK variant in Brisbane will lead to a city lockdown for three days from this evening. Cases are decreasing in Victoria and NSW. An escalation, particularly in Queensland over the weekend, will mute Australian equities which have suffered today.
Retail Sales should bounce back by 7.0% next week, and Westpac Consumer Confidence will outperform reinforcing Australia’s domestic recovery, as commodity prices reach multi-year highs. Covid-19 will probably subsume that data however.
h2 Japan/h2Shortened week with a public holiday on Monday. Japan Machinery Orders and PPI are expected to be quite negative, as reduced international demand and weak November bonuses sap international and domestic consumption. A COVID-19 state of emergency in Tokyo modest in scope and hardly a lockdown worth mentioning. Only an explosion of virus cases will undermine the equity rally.
Japan equities have rallied to multi-decade highs, coat tailing the US markets and as a prime beneficiary of the expected global recovery in 2021. We do not expect that sentiment to change markedly next week.
Monitor USD/JPY which has rallied over 1.0% in 24 hours after the Democrat clean sweep and Biden Presidency confirmed.That has pushed US yields higher with the Yen being very sensitive to yield differentials. A further move higher in the US 10-year next week could see a test of long-term resistance at 104.70, opening up a potentially large USD/JPY short squeeze.
h3 Key Economic Events/h3 h3 Monday/h3Original Post
/h2
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.